In Case You Missed It.
The latest and greatest from the TVC team and our portfolio.
Fierce Biotech
Argenx signs $1.5B pact to turn Unnatural Products' macrocyclic peptides to 'undruggable' targets
Argenx struck a deal worth $1.5B with Unnatural Products to develop macrocyclic peptide drugs for “undruggable” protein targets. UNP will handle early R&D, while argenx can take successful candidates to market. The deal includes milestones, royalties, and an equity investment.
Read More
Linkedin
Power100 Asset Managers In Venture Capital
Our firm is grateful to be honored alongside some of the best in the business. Thank you to Power100 Presented By Blueprint Capital Advisors LLC for the recognition.
Read More
Inc.com
Shizu Okusa Inc.com Founder Profile
Shizu Okusa has been recognized by Inc. as one of the 500 Female Founders to watch in 2025.
Read More
Summer Health
Summer Health Expands Pediatric Care Through Acquisition of Caraway Health
Summer Health has acquired Caraway Health, a platform specializing in care for Gen Z. This strategic acquisition marks a milestone at Summer Health to raise the healthiest generation.
Read More